Scientists develop 'Holy Grail' weight loss jab that burns fat without affecting appetite or muscle mass
In a first round human trial slimmers in Sweden taking the new drug-currently known as ATR-258-found they burnt fat yet preserved muscle mass.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.